Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 82 for

Edit search filters
  1. Study Of Rezafungin Compared To Standard Antimicrobial Regimen For Prevention Of Invasive Fungal Diseases In Adults Undergoing Allogeneic Blood And Marrow Transplantation (ReSPECT)

    Rochester, MN

  2. Physical Activity Intervention For Hematopoietic Cell Transplant Recipients And Caregivers

    Scottsdale/Phoenix, AZ

  3. Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT

    Rochester, MN

  4. Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation

    Rochester, MN

  5. HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

    Rochester, MN

  6. A Study To Evaluate The Pharmacokinetics (PK), Safety And Tolerability Of Pegcetacoplan In Patients With TA-TMA After Hematopoietic Stem Cell Transplantation (HSCT)

    Rochester, MN

  7. Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)

  8. Digital Stories And Psychosocial Wellbeing In Stem Cell Transplant Patients

    Scottsdale/Phoenix, AZ

  9. A Phase 2 Trial Of AMI MultiStem® Therapy In Subjects With Non-ST Elevation Acute Myocardial Infarction

    Scottsdale/Phoenix, AZ

  10. A Study Of Itolizumab In Combination With Corticosteroids For The First-Line Treatment Of Acute Graft Versus Host Disease (EQUATOR)

    Rochester, MN

.

Mayo Clinic Footer